P92 Low morbidity and no mortality of high-dose cyclophosphamide, thiotepa and mitoxantrone plus autologous peripheral blood stem cell support for high-risk breast cancer patients
1999 ◽
Vol 44
(0)
◽
pp. S13-S17
◽
2002 ◽
Vol 53
(5)
◽
pp. 1234-1239
◽
Keyword(s):
1996 ◽
Vol 32
(9)
◽
pp. 1490-1497
◽
Keyword(s):
2002 ◽
Vol 25
(4)
◽
pp. 347-353
◽
1997 ◽
Vol 19
(12)
◽
pp. 1223-1228
◽